Rights and permissions
About this article
Cite this article
ATG and muromonab CD3 increase cancer risk in renal transplant. React. Wkly. 752, 5 (1999). https://doi.org/10.2165/00128415-199907520-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199907520-00014